Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-02-25 @ 4:58 PM
Study NCT ID:
NCT03644069
Status:
UNKNOWN
Last Update Posted:
2019-03-19
First Post:
2018-05-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Sponsor:
ImmusanT, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-09
Completion Date Type:
ESTIMATED
First Submit Date:
2018-05-21
First Submit QC Date:
None
Study First Post Date:
2018-08-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-15
Last Update Post Date:
2019-03-19
Last Update Post Date Type:
ACTUAL